abstract Introduction: High level of vitamin D is associated with a better health status. The role of vitamin D deficiency in the incidence of cardiovascular events is demonstrated in previous studies. The current study aimed at evaluating the effect of vitamin D supplement therapy on serum lipids profile, as a risk factor for cardiovascular diseases. Methods: The current prospective cohort study included 221 patients admitted to a university hospital from March 2014 to March 2015. The baseline levels of the patients′ serum vitamin D and lipid profile of the study subjects were recorded. After three months treatment with vitamin D, the patients′ serum vitamin D level and lipid profile were reevaluated. The results before and after the supplement therapy were compared using statistical methods. Results: The mean age of the patients was 48.2 ± 14.0 years. The mean vitamin D level was 21.0 ± 16.6 ng/mL at baseline, which increased to 35.8 ± 32.7 ng/mL (P = 0.001) after a three-month vitamin D supplement therapy. Mean low-density lipoprotein (LDL) decreased from 112.1 ± 30.0 to 98.7 ± 31.7 mg/dL (P = 0.003) after the supplement therapy. Mean high-density lipoprotein (HDL) increased from 42.8 ± 11.2 to 44.5 ± 9.0 mg/dL, but the difference was insignificant before and after the treatment (P = 0.2). Mean cholesterol reduced from 183.8 ± 42.3 to 169.5 ± 41.9 mg/dL (P = 0.02) and the mean TG dropped from 147.5 ± 98.7 to 134.7 ± 71.1 mg/dL, (P = 0.1) after vitamin D intake.
INTRODuCTION
Vitamin D is one of the main causes of homeostasis in the bone and minerals. This vitamin increases the gastrointestinal absorption of the calcium and prevents/treats rickets [1] . On the other hand, the vitamin D receptors are spread throughout the body and therefore, extraskeletal effects of vitamin D are predictable [2] . Thus, along with the development of different methods to measure 25 (OH) D, which is the most common metabolite of vitamin D, several studies were performed to evaluate the level of this vitamin and according to their results, higher levels of vitamin D is associated with a better health status. Therefore, the lower levels of this vitamin can be considered as a predictor for type 2 diabetes mellitus, cancer, cardiovascular disorders, immunological problems, and mortality [3] . In a 11-year study on 4751 patients, subjects with lower levels of 25 (OH) D were about 32 times more at risk of mortality, compared with the ones with higher levels of 25 (OH) D [4] . In another study on 1739 patients from the offspring of the Framingham study, those with serum vitamin D levels of lower than 15 ng/mL had a risk ratio of 1.8 to cardiovascular events compared with those with 15 ng/mL serum vitamin D or more [5] . These studies suggested the use of vitamin D supplements to improve the general health status [6] . Association of vitamin D and cardiovascular disorders may be due to the role of this vitamin in decreasing the serum lipid levels confirmed by some cross sectional studies [7] [8] [9] . The current controlled trial aimed at evaluating the effect of vitamin D on the serum lipid levels, and examining the impact of vitamin D administration on the decrease of serum lipid levels. 
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Statistics
The data are expressed as mean ± standard deviation (SD), and the categorical variables as percentages. Continuous variables were compared by the Student t test or the Mann-Whitney U test, based on the distribution of data. Finally, the data were analyzed with SPSS version 19. A P-value < 0.05 was considered statistically significant.
RESulTS
A total of 221 patients referred to the Cardiology Clinic of Loghman-Hakim Hospital were enrolled in the study. The patients were put on vitamin D supplement. After three months of supplement therapy, only 50 patients including 21 (42%) males and 29 (58%) females referred for the follow-up visit. The mean age of the patients was 48.2 ± 14.0 years. The mean vitamin D level was 21.0 ± 16.6 ng/mL on admission. After supplement therapy, the mean vitamin D level increased to 35.8 ± 32.7 ng/mL (P = 0.001). Mean low-density lipoprotein (LDL) decreased from 112.1 ± 30.0 to 98.7 ± 31.7 mg/dL (P = 0.003). Mean high-density lipoprotein (HDL) increased from 42.8 ± 11.2 to 44.5 ± 9.0 mg/dL (P = 0.2). Mean cholesterol dropped from 183.8 ± 42.3 to 169.5 ± 41.9 mg/dL (P = 0.02), and the mean triglyceride (TG) reduced form 147.5 ± 98.7 to 134.7 ± 71.1 mg/dL, (P = 0.1) ( Table 1) .
DISCuSSION
The results of the current study showed that the mean levels of LDL and cholesterol significantly decreased during the three-month of supplement therapy. Although HDL and TG were changed, it was not statistically significant. Different mechanisms are proposed as the protective factors of vitamin D in heart failure. Serum level of 25 (OH) D is a significant factor showing the vitamin D reservoir of the body [10] . Receptor of vitamin D3 (calcitriol) exists in many of the cells including cardiomyocytes, endothelial cells, neurons, and immunological cells [10, 11] . Calcitriol is one of the most important regulators of the calcium metabolism and serum calcium homeostasis. Also, it acts as the cytokine excretion and intra-cellular calcium metabolism regulator [10] [11] [12] . Serum lipid levels have also an important role in the calcium metabolism. As previously described, calcium intake affects the body mass index (BMI) in different ways, the easiest of which, is the inhibition of lipid and free fatty acid absorption [13] . It seems that the most important effect of calcium is on the extracellular calcium control. Based on the results of different studies, agouti gene is a stimulator of calcium in the lipid tissue, which affects the lipolysis and lipogenesis and increases the lipid storage in the lipid tissue [14] . Calcitriol increases the synthesis of fatty acids and inhibits the calcium-dependent lipolysis [15] . Then, entrance of calcium into the cells by calcitriol is decreased. Higher intake of calcium, decreases the calcium entrance by 1 and 25 dihydroxycholecalciferol, inhibits the synthesis of fatty acids, and triggers the lipolytic activity [15] . Decreased plasma insulin by diet calcium is another mechanism of this effect. Insulin secretion is calcium-dependent and increased calcium is necessary to both first and second phases of insulin secretion [16] . Calcium also plays an important role in glucose uptake by binding to the skeletal cells receptors, insulin receptor affinity, and insulin sensitivity [17] . In a review study by Hao Wang et al., on 12 clinical trials, the mean change of LDL was 3.23 mg/ dL (0.55 to 5.90 mg/dL), while no changes were detected in the level of total cholesterol, TG, and HDL after the administration of vitamin D. However, they suggested further studies to confirm the effect of vitamin D on serum lipid profile [18] . As observed, results of their study were consistent with those of the current study in terms of LDL, HDL, and TG, except for cholesterol, which significantly decreased in the current study. [20] . A study by Schleithoff et al., evaluated the adjusting effects of vitamin D on inflammation. They showed that after a nine-month treatment with vitamin D in patients with heart failure, the inflammatory cytokine of tumor necrosis factor (TNF)-α decreased and anti-inflammatory cytokine of interleukin (IL)-10 increased [21] . In a study by Zittermann et al., serum level of vitamin D was significantly lower in patients with heart failure compared with the controls [22] . Witte et al., showed that low serum level of vitamin D is associated with the myocyte dysfunction, heart failure, and subsequently, acute cardiac death [23] . Many studies showed that in patients with metabolic syndrome, vitamin D level is lower, while some other studies rejected this hypothesis. In a study on 1654 Americans, [24] [25] [26] the lower levels of vitamin D was observed in patients with metabolic syndrome; the result was in agreement with those of some other studies. In a study by Moy on 380 individuals, subjects with vitamin D deficiency were at higher risk for the development of metabolic syndrome (OP = 1.73); in addition, BMI, waist circumference, and TG level were significantly different among the ones with normal and vitamin D deficiency [27] . In a study in China on 3262 people, the risk of metabolic syndrome was almost 1.52 times higher in the ones at the lowest quartile of vitamin D compared with the ones on the highest quartile. A significant diverse relation was observed between metabolic syndrome and level of vitamin D [28] . The most important limitations of the current study were the small sample size and lack of control group. Also, the study selected patients who referred to a cardiology clinic; therefore, the generalization of the results should be done cautiously.
CONCluSIONS
Treatment with vitamin D can significantly decrease the level of LDL and cholesterol in the patients, although it has no impact on the level of TG and HDL. Other prospective studies on the contributing risk factors are suggested in order to evaluate the impact of vitamin D level on lipid profile.
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